Integrichain Blog

Blog

Contracts & Pricing Rupal Patel
September 17, 2020

Additional Drug Reporting for NDA and ANDA Holders, FDA NSDE Structured...

2 Minute Read

Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.

Contracts & Pricing Rupal Patel
August 11, 2020

New Drug Pricing Executive Orders, Changes to 340B

2 Minute Read

Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.

Patient Access Mia Scioscia
July 27, 2020

Real-Time Data Insights and Actionability All in Single Access-Specific Platform

4 Minute Read

Refined patient data aggregation and enhanced inventory analytics. Read more about what's new in the latest ICyte Platform Summer Release.

Contracts & Pricing John Whitridge
July 22, 2020

New News From California: Pricing Transparency, State Supplemental Program

2 Minute Read

Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.

Contracts & Pricing Rupal Patel
June 19, 2020

The Latest Updates from the Centers for Medicare & Medicaid Services,...

2 Minute Read

Stay up-to-date with relevant, timely industry insights and regulatory updates that may impact pharmaceutical manufacturers.

Patient Access Sean McCarthy Edward Doran
June 10, 2020

The Four Challenge Cases in Patient Data Mastering

8 Minute Read

IntegriChain is utilizing AI and machine learning to develop risk score models that will allow Field Reimbursement Managers (FRMs) and similar functions to proactively intervene on behalf of patients...

Patient Access Lucas Dan
August 15, 2019

Utilizing AI and Machine Learning to Predict Challenging Patient Cases

3 Minute Read

IntegriChain is utilizing AI and machine learning to develop risk score models that will allow Field Reimbursement Managers (FRMs) and similar functions to proactively intervene on behalf of patients...

Patient Access Brandon Underwood
July 12, 2019

Cancellation Reasons Highlight the Opportunity to Proactively Support Stalled Patient Cases

3 Minute Read

The quality of status and sub-status data reported by SPs is an ongoing challenge that limits the actionability of data specialty brands have contracted to receive. Clearly, poor data...

Patient Access Brandon Underwood
February 7, 2019

Specialty Pharmacy Patient Status Data Quality Challenges and Solutions

4 Minute Read

Without visibility into each individual patient journey, your specialty brand cannot consistently intervene to help patients overcome barriers to therapy initiation and adherence. Today, the poor quality of specialty...

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand